Toxicity increases with combined chemo/radiation treatments for nasopharyngeal carcinoma

July 15, 2010

Although the standard practice of treating patients with advanced Nasopharyngeal Carcinoma using radiation and chemotherapy may reduce cancer deaths compared to patients treated with radiation alone, non-cancer related deaths and toxicity problems have been shown to increase, according to a recent study published online in The Journal of the National Cancer Institute.

Combining radiation and has been the long-standing standard treatment for nasopharyngeal carcinoma, ever since the Intergroup-0099 Study in the early nineties showed increased three-year overall survival for patients treated with the combined therapies. But there have been few data on the potential toxicities of these treatments. The NPC-990 Trial is the first study with data on toxicities and causes of non-cancer death.

To compare the toxicity profile and overall survival of patients treated with radiation and chemotherapy compared to those treated with radiation therapy alone, Anne W.M. Lee of the Hong Kong Nasopharyngeal Cancer Study Group and colleagues, compared two randomly assigned treatment groups of patients with advanced nasopharyngeal : in the first group 172 patients were treated with radiation alone, compared to a second group of 176 patients treated with both radiation and chemotherapy.

Patients from five hospitals in Hong Kong and Canada were enrolled in the trial, which lasted from March 1999, until February 2004. Patients were followed up at least every three months during the first three years, and then every six months thereafter until death.

The researchers found that the patients taking combined radiation and chemotherapy experienced a statistically significant reduction in deaths due to . But they also experienced a statistically significant increase in deaths due to treatment-related toxicities and other causes. Indeed, there was an acute toxicity rate of 83%, compared to 53% in the group alone.

The authors also reported a "worrisome increase" in non-cancer deaths in the combined therapies group, including infection, second malignancy and suicide. This finding "could narrow the actual magnitude of survival gain," they write.

Explore further: Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation

Related Stories

High-dose radiation improves lung cancer survival

April 8, 2009

Higher doses of radiation combined with chemotherapy improve survival in patients with stage III lung cancer, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

( -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.